Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP980583.RAezztikzMjL-wmT-5ZQpcsQWCaaoGJiEP-rVT6vw2IqI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP980583.RAezztikzMjL-wmT-5ZQpcsQWCaaoGJiEP-rVT6vw2IqI130_assertion type Assertion NP980583.RAezztikzMjL-wmT-5ZQpcsQWCaaoGJiEP-rVT6vw2IqI130_head.
- NP980583.RAezztikzMjL-wmT-5ZQpcsQWCaaoGJiEP-rVT6vw2IqI130_assertion description "[HER2 gene amplification approaches might be an optimal HER2/neu testing strategy for the selection of HER2+ GC patients who are candidates to be treated with anti-HER2 therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP980583.RAezztikzMjL-wmT-5ZQpcsQWCaaoGJiEP-rVT6vw2IqI130_provenance.
- NP980583.RAezztikzMjL-wmT-5ZQpcsQWCaaoGJiEP-rVT6vw2IqI130_assertion evidence source_evidence_literature NP980583.RAezztikzMjL-wmT-5ZQpcsQWCaaoGJiEP-rVT6vw2IqI130_provenance.
- NP980583.RAezztikzMjL-wmT-5ZQpcsQWCaaoGJiEP-rVT6vw2IqI130_assertion SIO_000772 22569536 NP980583.RAezztikzMjL-wmT-5ZQpcsQWCaaoGJiEP-rVT6vw2IqI130_provenance.
- NP980583.RAezztikzMjL-wmT-5ZQpcsQWCaaoGJiEP-rVT6vw2IqI130_assertion wasDerivedFrom befree-2016 NP980583.RAezztikzMjL-wmT-5ZQpcsQWCaaoGJiEP-rVT6vw2IqI130_provenance.
- NP980583.RAezztikzMjL-wmT-5ZQpcsQWCaaoGJiEP-rVT6vw2IqI130_assertion wasGeneratedBy ECO_0000203 NP980583.RAezztikzMjL-wmT-5ZQpcsQWCaaoGJiEP-rVT6vw2IqI130_provenance.